Walfred S Saari

This inventor holds 52 USPTO granted patents, primarily in Pharmaceutical Compounds (CPC class 4242). Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp.. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Walfred S Saari. Retrieved from https://idiyas.com/inventor/walfred-s-saari

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 52

% Patents Active = 100.0

Average Co-Inventor Count = 1.7

ph-index = 12

Forward Citations = 435(Granted Patents)

Forward Citations (Not Self Cited) = 379(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Pennsburg, PA (US) (1978)
Landsdale, PA (US) (1989)
Lansdale, PA (US) (1976 - 1996)
St. George, ME (US) (1996)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

Years Active: 1976-1996

Loading Chart...

Areas of Expertise:

HIV Reverse Transcriptase

Farnesyl-Protein Transferase

Bone Resorption Inhibitors

Gastrin Releasing Peptide

Nitrobenzenesulfonamides

Radiation Therapy Adjuncts

Melanoma Chemotherapy

Piperazine Derivatives

Analgesic Compounds

Amino Acid Esters

Nitropyrazinyl Compounds

Carbamates

52 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5576313 - Inhibitors of farnesyl-protein transferase (1996-11-19),

2. 5527819 - Inhibitors of HIV reverse transcriptase (1996-06-18),

3. 5495047 - Fused tricyclic compounds, pharmaceutical compositions containing them (1996-02-27),

4. 5308854 - Inhibitors of HIV reverse transcriptase (1994-05-03),

5. 5227506 - Acyloxymethyl esters of bisphosphonic acids as bone resorption inhibitors (1993-07-13),

6. 5183815 - Bone acting agents (1993-02-02),

7. 5028692 - Gastrin releasing peptide antagonist (1991-07-02),

8. 5019647 - Gastrin releasing peptide antagonist (1991-05-28),

9. 4943561 - Gastrin releasing peptide antagonist (1990-07-24),

10. 4942226 - Halogenated pyrimidine nucleosides and their derivatives (1990-07-17),

11. 4935443 - N-substituted-3-nitro-4-(ureidooxymethyl)-benzenesulfonamides as (1990-06-19),

12. 4897423 - Dinitrobenzenesulfonamides (1990-01-30),

13. 4892951 - Derivatives of 3-nitropyridines useful as adjuncts to radiation therapy (1990-01-09),

14. 4880821 - .alpha.-nitroalkylnitrobenzenesulfonamides (1989-11-14),

15. 4853415 - 2-(substituted sulfamyl) derivatives of 4-nitrobenzamide as radiation (1989-08-01),

Title: The Inventor Profile of Walfred S Saari

Introduction: Walfred S Saari, a notable inventor based in Lansdale, PA (US), has made significant contributions to the field of innovation with his creative and groundbreaking ideas.

Latest Patents: Walfred S Saari holds several patents in various industries, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his career, Walfred S Saari has demonstrated a keen ability to identify gaps in the market and develop unique solutions to address them. His inventions have not only improved existing technologies but have also paved the way for new advancements in the industry.

Collaborations: Walfred S Saari has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have been instrumental in turning his ideas into tangible products that have had a positive impact on society.

Conclusion: Walfred S Saari's passion for innovation and his relentless pursuit of excellence have established him as a respected figure in the world of inventors. His contributions continue to inspire future generations of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]